GEMSTONE Oncology logo
MenuClose

Role of Hereditary and Somatic Genetic Testing in Ovarian Cancer

  • Role of Hereditary and Somatic Genetic Testing in Ovarian Cancer ‐ Slide Module
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide

Download Slide Module

Genetic aberrations impact ovarian cancer prognosis and treatment decisions.

Certain mutations, such as those affecting the BRCA1/2 genes, serve as biomarkers and have been shown to increase the risk of ovarian cancer, as well as predict outcomes to specific treatments.

Because of this, molecular profiling is important in counseling patients and guiding screening and treatment strategies.

Explore the module further to learn more about the role of hereditary and somatic genetic testing in ovarian cancer—or download the module for later review offline.

The identification of hereditary and somatic genetic mutations is an important aspect of ovarian cancer management. Genetic testing can guide decisions for both preventative care and active treatment.

BRIAN M. SLOMOVITZ, MD
University of Miami
GEMSTONE Committee Member: Brian Slomovitz, MD
GEMSTONE Oncology infographic ‐ impact ovarian cancer prognosis and treatment decisions

Download Infographic